Vivaldo Moura-Neto

15PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 28, 2026
Proangiogenic Properties of Extracellular Vesicles Secreted by Endothelial Cells Reversibly Primed for Anoikis: A Possible Autocrine Mechanism Induced by Astrocytoma Extracellular Matrix.

Aline O da Silva-de-Barros, Tercia Rodrigues Alves, Laila Ribeiro-Fernandes

|Jul 12, 2025
A Pharmacologic Approach Against Glioblastoma-A Synergistic Combination of a Quinoxaline-Based and a PI3K/mTOR Dual Inhibitor.

Vitória Santório de São José, Bruno Marques Vieira, Camila Saggioro de Figueiredo

|Jun 18, 2025
In vitro Antitumor Activity and Electrochemical Studies of Bio-Electroactive Anthraquinone Derivatives in Glioblastoma.

Suellen Maria A DA Silva, João Kaycke S DA Silva, Joice Fragoso O DE Araújo

|May 14, 2025
The Role of RAS in CNS Tumors: A Key Player or an Overlooked Oncogene?

Isabel de Souza Barbosa, Carlos Pilotto Heming, Vivaldo Moura Neto

|Jan 08, 2025
Repurposing Osimertinib and Gedatolisib for Glioblastoma Treatment: Evidence of Synergistic Effects in an In Vitro Phenotypic Study.

Vitória Santório de São José, Bruno Marques Vieira, Vivaldo Moura Neto

Pageof 3